Thanks  to all the amazing doctors who joined our Roundtable Dinner last  Friday! The discussions were truly enlightening as we shared our  latest endeavors in AI-powered Clinical Data Management and  Comprehensive Genomic Profiling. We were honored to have Alexa Jen, Guardant Health AMEA Genomics  Lead, present the groundbreaking results from the COSMOS-CRC-01 trial,  which showcased an outstanding 90.7% recurrence-free survival rate at 24  months for Colorectal Cancer patients with a negative Guardant Reveal  report after surgery [1].

With  Guardant360's tissue panel upgraded to encompass 498 genes and the  liquid biopsy panel now covering 739 genes & methylation-based Tumor  Fraction (i.e. a prognostic indicator), we embark together on an  exciting journey of Comprehensive Genomic Profiling.  The evening was  filled with collaboration and innovation, and we are deeply grateful for  the opportunity to bring together such a remarkable group of  professionals.

Special thanks to Dr. Amy Chang,  Dr. Alan Ka-Lun KAI, Dr. Conrad Lee, Dr. Kenny Ng and Dr. Louisa Lui for coming to our event! 😊

[1] Nakamura et al., ASCO GI 2024 Abstract#180

Check Out: https://www.linkedin.com/posts/codexgenetics_annual-oncology-roundtable-tackling-minimal-activity-7222085202162896896-Ovcq?utm_source=share&utm_medium=member_desktop